Effect of SGLT2i on Cardiovascular Outcomes in Patients With Preserved Ejection Fraction Heart Failure After Acute Myocardial Infarction

Abstract

Get full access to this article

View all access options for this article.

References

Calcagno

Issa

Canova

, et al. Impact of SGLT2i on cardiovascular outcomes following acute myocardial infarction with heart failure with preserved ejection fraction: propensity-matched Registry Study. Angiology. Published online June 19, 2025. doi:10.1177/00033197251345853

Aydın

Demirkıran

Orta

C-reactive protein-albumin-lymphocyte (CALLY) index and length of hospital stay in patients with heart failure. Angiology. Published online July 5, 2025. doi:10.1177/00033197251355348

Kaplangoray

Aydın

Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure. Kardiologiia. 2023;63(2):46-51. Russian.

Tentolouris

Vlachakis

Tzeravini

Eleftheriadou

Tentolouris

SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects. Int J Environ Res Public Health. 2019;16(16):2965.

Hayashi

Fukui

Nakanishi

, et al. Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin. Cardiovasc Diabetol. 2017;16(1):8.